Del 9 i serien Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy

The Resistance of Cervical Cancer to Chemotherapy and its Reversal

Inbunden, Engelska, 2026

2 319 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling pathways during chemoresistance in cervical cancer, the involvement of genes in drug resistance, and introduces long noncoding RNAs as novel biomarkers.

In 10 chapters, this book first provides an introduction and history of cervical cancer; next, it discusses the influence of viruses on cervical cancer and finally, it describes therapies to overcome chemotherapy resistance in cervical cancer. This is the perfect reference to provide the fundamental base of knowledge needed for oncologists, pharmacologists, translational investigators, immunotherapists, scientists, and clinicians interested in building a comprehensive understanding of the field.

Focuses on the aspects of cervical cancer resistance towards therapies such as chemoresistance and radioresistance
Discusses the sensitizing agents that are being developed for the improvement of current therapies and better management of cervical cancer
Identifies the molecular mechanism of HPV integration and cervical cancer development

Produktinformation

Utgivningsdatum2026-03-20
Mått191 x 235 x 24 mm
Vikt450 g
FormatInbunden
SpråkEngelska
SerieBreaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy
Antal sidor364
FörlagElsevier Science
ISBN9780443223525

Tillhör följande kategorier

Onkologi inom Medicin
Gynekologi och obstetrik inom Medicin

Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. After completing his Ph.D, he has joined for his Postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea. He has worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. He is also involved in the identifying the role of T0070907/EGCG/cordycepin on cervical cancer cells. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) and serving as Associate Professor and Head at Cancer Research Centre working in the area of development of EGFR TKIs for the treatment/management of cervical cancer/pancreatic cancer.

Role of Wnt/β‑catenin signaling pathway in cervical cancer: Strategies to overcome therapeutic resistanceTargeting epigenetic regulatory machinery to overcome cervical cancer chemoresistanceThe role of immune checkpoint proteins PD1 and PD‑L1 during cancer resistanceAdvancements in radiotherapy: transforming cervical cancer treatmentPathogenesis of human papillomavirus induced carcinogenesis: insights on in vivo models and prophylactic strategiesSubcellular transport of epidermal growth factor receptor: diverse approaches in targeting epidermal growth factor receptor‑driven cervical carcinomaStructural insights into Human papillomavirus E6 and E7 oncoproteins: implications for drug design and therapeutic targetingCritical insights to understand the underlying mechanisms in cervical cancer metastasisAdvancements of cytology in cervical cancerInsights on molecular mechanisms of chemoresistance in cervical cancerComputational techniques to study the cervical cancerAdvances in nanotechnology‑based drug development and delivery for cervical cancer therapeutic strategies